VAP-1, Eotaxin3 and MIG as potential atherosclerotic triggers of severe calcified and stenotic human aortic valves: effects of statins (Q33284176)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	VAP-1, Eotaxin3 and MIG as potential atherosclerotic triggers of severe calcified and stenotic human aortic valves: effects of statins	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

VAP-1, Eotaxin3 and MIG as potential atherosclerotic triggers of severe calcified and stenotic human aortic valves: effects of statins (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

object named as

Thomas Anger

1

0 references

Christian Stumpf

object named as

Christian Stumpf

8

0 references

Theodor Fischlein

6

object named as

Theodor Fischlein

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Stephan M Ensminger

5

object named as

Stephan M Ensminger

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

Falk K Pohle

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Lukas Kandler

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Thomas Barthel

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Michael Weyand

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Werner G Daniel

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Christoph D Garlichs

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

24 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Experimental and Molecular Pathology

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

83

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

435-442

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Acquired aortic stenosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Hypercholesterolemic valvulopathy: an aspect of malignant atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Osteopontin expression and calcium content in human aortic valves

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Inflammation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Factors associated with calcific aortic valve degeneration in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Expression of endothelial cell adhesion molecules on heart valves: up-regulation in degeneration as well as acute endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Osteopontin is expressed in human aortic valvular lesions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Aortic stenosis and hyperlipidemia: establishing a cause-effect relationship

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Aortic stenosis: even mild disease is significant

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

New insights into the progression of aortic stenosis: implications for secondary prevention.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Association of cardiovascular risk factors to aortic valve calcification as quantified by electron beam computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Human Aortic Valve Calcification Is Associated With an Osteoblast Phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Progression of aortic stenosis in adults: new appraisal using Doppler echocardiography

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Progression of human aortic valve stenosis is associated with tenascin-C expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

HMG CoA reductase inhibitor (statin) and aortic valve calcium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Lysophosphatidylcholine posttranscriptionally inhibits interferon-gamma-induced IP-10, Mig and I-Tac expression in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Statins reduce inflammation in atheroma of nonhuman primates independent of effects on serum cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Aortic valve replacement for the calcified ascending aorta in homozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2007.02.008

7 January 2021

Identifiers

10.1016/J.YEXMP.2007.02.008

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33284176&oldid=2211056088"